S006 Consultative Dermatology for the Hospitalized Patient
DESCRIPTION
The ultimate goal of this session is to equip attendees with practical and immediately applicable skills for inpatient and consult work within the house of medicine. In this high-yield session, expert Dermatology Hospitalists will review some of the most common skin diseases seen in consultation. Topics include: pediatric emergencies, severe cutaneous adverse reactions, retiform purpura, hidradenitis suppurativa, tele-consults, and oncodermatologic emergencies. Information will be delivered in high-impact 20-minute specialty segments with an emphasis on practical practice points that are not readily available in the literature or textbooks.
LEARNING OBJECTIVES
Identify cutaneous manifestations of systemic diseases, medication reactions, and infections as they present in the hospitalized patient with skin disease.
Develop a working differential diagnosis, management plan, and treatment algorithm for hospitalized patients with skin disease.
Draw from a set of high-yield clinical pearls for performing inpatient and consultative dermatology care.
SCHEDULE
9:00 AM
Intro and Welcome
Helena Beth Pasieka, MD, FAAD
9:05 AM
Inpatient Management of Hidradenitis Suppurativa
Freba Farhat, MD, FAAD
9:30 AM
Oncodermatology Emergencies
Steven T. Chen, MD, MPH, FAAD
9:55 AM
Pediatric Dermatology Consults
Anna Yasmine Kirkorian, MD, FAAD
10:20 AM
Questions and Answers
10:35 AM
Teledermatology Consults
Lindsay Chaney Strowd, MD, FAAD
11:00 AM
Retiform Purpura: A Dermatologic Emergency
Robert Micheletti, MD, FAAD
11:25 AM
Panel Discussion / Questions and Answers
DIRECTOR
Helena Beth Pasieka, MD, FAAD
SPEAKERS
Steven T. Chen, MD, MPH, FAAD
Freba Farhat, MD, FAAD
Anna Yasmine Kirkorian, MD, FAAD
Robert Micheletti, MD, FAAD
Lindsay Chaney Strowd, MD, FAAD
HANDOUTS
DISCLOSURES
Steven T. Chen, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Vertex Pharmaceuticals Incorporated – Employee (w-2 relationship)(Salary); VisualDx – Independent Contractor(Fees);
Freba Farhat, MD, FAAD
No financial relationships exist with ineligible companies.
Anna Yasmine Kirkorian, MD, FAAD
Dermavant Sciences, Inc. – Advisory Board(Honoraria); Ebix Inc. – Other(Fees); Incyte – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Fees); Regeneron – Other(Grants/Research Funding); Verrica Pharmaceuticals Inc – Advisory Board(Fees);
Robert Micheletti, MD, FAAD
Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Insmed – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);
Helena Beth Pasieka, MD, FAAD
No financial relationships exist with ineligible companies.
Lindsay Chaney Strowd, MD, FAAD
Eli Lilly and Company – Advisory Board(Fees);